910297-52-8: Dasatinib N-Oxide

Status: In-stock

Dasatinib N-Oxide (CAS No.: 910297-52-8) is a biotransformation product of Dasatinib which is an orally administered small-molecule blocker of an array of tyrosine kinases amongst which are BCR-ABL and SRC family kinases that are evaluated for the treatment of adults with naive chronic-phase chronic myeloid leukemia (CML).

Additional information on CAS 910297-52-8

Catalogue No. VL4870001
CAS No. 910297-52-8
Molecular Formula C22H26ClN7O3S
Molecular Weight 504.00 g/mol
Parent drug Dasatinib
IUPAC Name 4-(6-((5-((2-chloro-6-methylphenyl)carbamoyl)thiazol-2-yl)amino)-2-methylpyrimidin-4-yl)-1-(2-hydroxyethyl)piperazine 1-oxide
Synonyms N-[2-Chloro-6-methylphenyl]-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide N-Oxide;
References Christopher, Lisa J., et al. “Metabolism and Disposition of Dasatinib after Oral Administration to Humans.” Drug Metabolism and Disposition, vol. 36, no. 7, Apr. 2008, pp. 1357–64, https://doi.org/10.1124/dmd.107.018267.?McCormack, Paul L., and Susan J. Keam. “Dasatinib.” Drugs, vol. 71, no. 13, Sept. 2011, pp. 1771–95, https://doi.org/10.2165/11207580-000000000-00000.
Status In-stock

Request a quote

We Respond Within a Few Hours - Whether You're a New or Existing Client

Payment Made Simple: All major Credit/Debit cards accepted

Streamlined 3-Step Process from Quotes to Orders:

Product name:

910297-52-8: Dasatinib N-Oxide

"*" indicates required fields

Products quotation
This field is for validation purposes and should be left unchanged.